SCHEMBL19659656

SCHEMBL19659656

NC(=O)c1nc2c(-c3ccccc3)nccn2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.46
TMIGD3 P0DMS9 4/20 0.39
ADORA3 P0DMS8 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ADORA2A P29274 1/20 0.39
POLB P06746 1/20 0.38
NTRK1 P04629 3/20 0.38
PIM1 P11309 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PDE10A Q9Y233 1/20 0.37
CDC7 O00311 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
DBF4 Q9UBU7 1/20 0.37
DHODH Q02127 1/20 0.37
MAP2K1 Q02750 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
MAP2K3 P46734 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19659381 0.77 PARP1 (0.55) PARP1L3MBTL1ALDH1A1DHODHCLK4
SCHEMBL19105 0.77 MAPK8 (0.55) PARP1PIM1CDC7CDK2CLK4
SCHEMBL15210509 0.70 POLB (0.48) PARP1L3MBTL1POLBNTRK1PIM1
SCHEMBL19913 0.70 JAK2 (0.50) ADORA2ACDK2
SCHEMBL15210475 0.68 JAK2 (0.54) ADORA2APDE10ACLK4DYRK1B
SCHEMBL30035416 0.66 PARP1 (0.44) PARP1L3MBTL1KDM4EALDH1A1MAP2K1
SCHEMBL7040079 0.66 JAK2 (0.48) PARP1L3MBTL1ALDH1A1PDE10A
SCHEMBL3468178 0.65 ADORA2A (0.50) PARP1L3MBTL1ADORA2APOLBKDM4E
SCHEMBL20010 0.65 KDR (0.52) PDE10A
SCHEMBL20963 0.65 JAK2 (0.40) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3760625-A1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES F. Hoffmann-La Roche AG (CH) 2021-01-06 EP disclosed
WO-2017004500-A9 BICYCLIC LACTAMS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2017-11-30 WO disclosed